Danxia Gu
Impact in
- Molecular Medicine top 0.02%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 24
-
- Bacterial Identification and Susceptibility Testing 3
- Co-authors
- Rong Zhang (22 shared papers)Hong-Wei Zhou (10 shared papers)Yang Wang (4 shared papers)Jianzhong Shen (3 shared papers)JAMES M. SPENCER (1 shared paper)Luchao Lv (1 shared paper)Hongwei Ren (1 shared paper)Baolei Dong (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)Frontiers in Microbiology (4 papers)International Journal of Antimicrobial Agents (2 papers)The Lancet Infectious Diseases (2 papers)Nature Communications (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Danxia Gu
30 papers receiving 6.1k citations
Danxia Gu's Hit Papers
Peers
Comparison fields: 5 of 97
- Molecular Medicine 4.5k
- Applied Microbiology and Biotechnology 441
- Endocrinology 374
- Microbiology 244
- Clinical Biochemistry 177
Countries citing papers authored by Danxia Gu
This map shows the geographic impact of Danxia Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danxia Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danxia Gu more than expected).
Fields of papers citing papers by Danxia Gu
This network shows the impact of papers produced by Danxia Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danxia Gu. The network helps show where Danxia Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Danxia Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study Hit paper breakdown → | 2015 | 4513 |
| 2 | A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study Hit paper breakdown → | 2017 | 852 |
| 3 | 2015 | 204 | |
| 4 | 2015 | 88 | |
| 5 | 2021 | 83 | |
| 6 | 2020 | 65 | |
| 7 | 2016 | 51 | |
| 8 | 2019 | 37 | |
| 9 | 2022 | 36 | |
| 10 | 2015 | 33 | |
| 11 | 2016 | 32 | |
| 12 | 2019 | 30 | |
| 13 | 2013 | 29 | |
| 14 | 2016 | 25 | |
| 15 | 2015 | 22 | |
| 16 | 2017 | 20 | |
| 17 | 2018 | 19 | |
| 18 | 2018 | 17 | |
| 19 | 2023 | 17 | |
| 20 | 2022 | 15 |
About Danxia Gu
Danxia Gu is a scholar working on Molecular Medicine, Clinical Biochemistry, Endocrinology, Biomaterials and Infectious Diseases, having authored 30 papers that have together received 6.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (24 papers), Bacterial Identification and Susceptibility Testing (3 papers), Escherichia coli research studies (1 paper), Infections and bacterial resistance (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Antimicrobial Resistance in Staphylococcus (1 paper). The work is most often cited by research in Molecular Medicine (4.5k citations), Applied Microbiology and Biotechnology (441 citations), Endocrinology (374 citations), Microbiology (244 citations) and Clinical Biochemistry (177 citations). Danxia Gu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Rong Zhang, Hong-Wei Zhou, Yang Wang, Jianzhong Shen, JAMES M. SPENCER, Luchao Lv, Hongwei Ren, Baolei Dong, Guo‐Bao Tian and Dandan He. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Frontiers in Microbiology, International Journal of Antimicrobial Agents, The Lancet Infectious Diseases and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.